Showing 1 - 2 results of 2 for search 'Anthony D. Piscopio', query time: 0.02s Refine Results
  1. 1
    First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors

    First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors by Anna R. Schreiber, Jodi A. Kagihara, Bradley R. Corr, S. Lindsey Davis, Christopher Lieu, Sunnie S. Kim, Antonio Jimeno, D. Ross Camidge, Jud Williams, Amy M. Heim, Anne Martin, John A. DeMattei, Nisha Holay, Todd A. Triplett, S. Gail Eckhardt, Kevin Litwiler, James Winkler, Anthony D. Piscopio, Jennifer R. Diamond

    Published 2023-12-01
    Get full text
    Article
  2. 2
    Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy

    Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy by Nisha Holay, Nisha Holay, Alexander Somma, Mark Duchow, Milad Soleimani, Milad Soleimani, Anna Capasso, Srividya Kottapalli, Joshua Rios, Uma Giri, Jennifer Diamond, Jennifer Diamond, Anna Schreiber, Anthony D. Piscopio, Carla Van Den Berg, Carla Van Den Berg, Carla Van Den Berg, S. Gail Eckhardt, S. Gail Eckhardt, Todd A. Triplett, Todd A. Triplett

    Published 2023-09-01
    Get full text
    Article

Search Tools: